Imugene Historical Balance Sheet

IMU Stock

0.04 0 5.26%

Trend analysis of Imugene balance sheet accounts such as Other Current Liabilities of 23.5 M or Total Current Liabilities of 30.8 M provides information on Imugene's total assets, liabilities, and equity, which is the actual value of Imugene to its prevalent stockholders. By breaking down trends over time using Imugene balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Imugene latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Imugene is a good buy for the upcoming year.

Imugene Inventory

(3.6 Million)

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Imugene Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Imugene at a specified time, usually calculated after every quarter, six months, or one year. Imugene Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Imugene and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Imugene currently owns. An asset can also be divided into two categories, current and non-current.

Imugene Balance Sheet Chart

At this time, Imugene's Cash is comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 40.3 M in 2024, despite the fact that Other Stockholder Equity is likely to grow to (147.9 M).

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Short Term Investments Net Invested Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of Imugene assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Imugene books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Imugene balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Imugene are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Short Term Investments

Short Term Investments is an item under the current assets section of Imugene balance sheet. It contains any investments Imugene undertook that will expire in less than one year. These accounts contain financial instruments such as stocks or bonds that Imugene can easily liquidate in the marketplace.

Net Invested Capital

The total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents.

Most accounts from Imugene's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Imugene current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imugene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	673.4K	553.5K	1.5M	1.6M
Total Assets	147.6M	197.1M	151.4M	159.0M

Short Long Term Debt Total Total Assets

Imugene balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Inventory
Total Assets		0.04	0.67	0.72	0.99	0.85	0.96	-0.98	-0.84	0.85	0.99	0.89	0.64	0.99	0.97	0.89	0.93	0.69	-0.97	0.73	0.84	0.99	0.71	0.88	0.96	-0.76
Short Long Term Debt Total	0.04		0.49	0.47	-0.04	0.36	0.13	-0.02	-0.41	0.37	0.04	-0.11	-0.39	0.05	0.11	-0.01	0.12	0.27	-0.16	0.45	0.37	0.07	0.46	-0.15	0.26	0.13
Other Current Liab	0.67	0.49		0.99	0.57	0.95	0.82	-0.56	-0.96	0.89	0.59	0.7	0.46	0.6	0.73	0.68	0.74	0.9	-0.72	0.99	0.95	0.64	1.0	0.65	0.85	-0.44
Total Current Liabilities	0.72	0.47	0.99		0.63	0.97	0.86	-0.62	-0.98	0.93	0.65	0.74	0.49	0.66	0.78	0.72	0.79	0.9	-0.77	1.0	0.97	0.69	1.0	0.69	0.89	-0.49
Total Stockholder Equity	0.99	-0.04	0.57	0.63		0.78	0.93	-0.99	-0.77	0.79	0.99	0.87	0.63	0.99	0.95	0.86	0.9	0.61	-0.95	0.64	0.77	0.99	0.62	0.86	0.91	-0.77
Property Plant And Equipment Net	0.85	0.36	0.95	0.97	0.78		0.94	-0.76	-0.98	0.97	0.78	0.83	0.57	0.79	0.9	0.81	0.88	0.87	-0.86	0.97	1.0	0.82	0.96	0.79	0.95	-0.61
Current Deferred Revenue	0.96	0.13	0.82	0.86	0.93	0.94		-0.91	-0.93	0.91	0.93	0.9	0.7	0.93	0.96	0.86	0.91	0.79	-0.95	0.86	0.94	0.95	0.85	0.88	0.98	-0.67
Net Debt	-0.98	-0.02	-0.56	-0.62	-0.99	-0.76	-0.91		0.76	-0.77	-1.0	-0.8	-0.59	-1.0	-0.93	-0.8	-0.86	-0.55	0.96	-0.62	-0.75	-0.99	-0.61	-0.79	-0.91	0.71
Retained Earnings	-0.84	-0.41	-0.96	-0.98	-0.77	-0.98	-0.93	0.76		-0.94	-0.79	-0.8	-0.52	-0.79	-0.87	-0.8	-0.87	-0.88	0.87	-0.98	-0.98	-0.82	-0.97	-0.76	-0.96	0.58
Accounts Payable	0.85	0.37	0.89	0.93	0.79	0.97	0.91	-0.77	-0.94		0.8	0.8	0.53	0.8	0.91	0.8	0.87	0.82	-0.88	0.93	0.97	0.83	0.92	0.76	0.94	-0.63
Cash	0.99	0.04	0.59	0.65	0.99	0.78	0.93	-1.0	-0.79	0.8		0.81	0.59	1.0	0.94	0.81	0.87	0.57	-0.97	0.65	0.78	1.0	0.64	0.8	0.92	-0.71
Non Current Assets Total	0.89	-0.11	0.7	0.74	0.87	0.83	0.9	-0.8	-0.8	0.8	0.81		0.69	0.81	0.91	0.97	0.93	0.85	-0.81	0.76	0.82	0.83	0.71	1.0	0.87	-0.82
Non Currrent Assets Other	0.64	-0.39	0.46	0.49	0.63	0.57	0.7	-0.59	-0.52	0.53	0.59	0.69		0.6	0.61	0.57	0.5	0.47	-0.61	0.49	0.57	0.6	0.49	0.68	0.59	-0.41
Cash And Short Term Investments	0.99	0.05	0.6	0.66	0.99	0.79	0.93	-1.0	-0.79	0.8	1.0	0.81	0.6		0.94	0.81	0.87	0.58	-0.97	0.66	0.78	1.0	0.65	0.8	0.93	-0.71
Net Receivables	0.97	0.11	0.73	0.78	0.95	0.9	0.96	-0.93	-0.87	0.91	0.94	0.91	0.61	0.94		0.92	0.96	0.74	-0.93	0.79	0.89	0.96	0.77	0.89	0.96	-0.81
Common Stock Total Equity	0.89	-0.01	0.68	0.72	0.86	0.81	0.86	-0.8	-0.8	0.8	0.81	0.97	0.57	0.81	0.92		0.97	0.85	-0.79	0.74	0.8	0.83	0.69	0.97	0.87	-0.92
Common Stock Shares Outstanding	0.93	0.12	0.74	0.79	0.9	0.88	0.91	-0.86	-0.87	0.87	0.87	0.93	0.5	0.87	0.96	0.97		0.83	-0.86	0.8	0.86	0.89	0.76	0.92	0.93	-0.89
Non Current Liabilities Total	0.69	0.27	0.9	0.9	0.61	0.87	0.79	-0.55	-0.88	0.82	0.57	0.85	0.47	0.58	0.74	0.85	0.83		-0.67	0.92	0.87	0.62	0.88	0.83	0.81	-0.64
Other Stockholder Equity	-0.97	-0.16	-0.72	-0.77	-0.95	-0.86	-0.95	0.96	0.87	-0.88	-0.97	-0.81	-0.61	-0.97	-0.93	-0.79	-0.86	-0.67		-0.77	-0.86	-0.97	-0.76	-0.79	-0.96	0.63
Total Liab	0.73	0.45	0.99	1.0	0.64	0.97	0.86	-0.62	-0.98	0.93	0.65	0.76	0.49	0.66	0.79	0.74	0.8	0.92	-0.77		0.97	0.69	0.99	0.71	0.89	-0.51
Property Plant And Equipment Gross	0.84	0.37	0.95	0.97	0.77	1.0	0.94	-0.75	-0.98	0.97	0.78	0.82	0.57	0.78	0.89	0.8	0.86	0.87	-0.86	0.97		0.81	0.97	0.78	0.95	-0.59
Total Current Assets	0.99	0.07	0.64	0.69	0.99	0.82	0.95	-0.99	-0.82	0.83	1.0	0.83	0.6	1.0	0.96	0.83	0.89	0.62	-0.97	0.69	0.81		0.68	0.82	0.95	-0.72
Short Term Debt	0.71	0.46	1.0	1.0	0.62	0.96	0.85	-0.61	-0.97	0.92	0.64	0.71	0.49	0.65	0.77	0.69	0.76	0.88	-0.76	0.99	0.97	0.68		0.66	0.88	-0.46
Intangible Assets	0.88	-0.15	0.65	0.69	0.86	0.79	0.88	-0.79	-0.76	0.76	0.8	1.0	0.68	0.8	0.89	0.97	0.92	0.83	-0.79	0.71	0.78	0.82	0.66		0.84	-0.84
Common Stock	0.96	0.26	0.85	0.89	0.91	0.95	0.98	-0.91	-0.96	0.94	0.92	0.87	0.59	0.93	0.96	0.87	0.93	0.81	-0.96	0.89	0.95	0.95	0.88	0.84		-0.69
Inventory	-0.76	0.13	-0.44	-0.49	-0.77	-0.61	-0.67	0.71	0.58	-0.63	-0.71	-0.82	-0.41	-0.71	-0.81	-0.92	-0.89	-0.64	0.63	-0.51	-0.59	-0.72	-0.46	-0.84	-0.69

Click cells to compare fundamentals

Imugene Account Relationship Matchups

Imugene balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	65.2M	71.8M	147.6M	197.1M	151.4M	159.0M
Short Long Term Debt Total	69.3K	271.0K	673.4K	553.5K	1.5M	1.6M
Other Current Liab	1.8M	3.6M	2.7M	3.6M	22.4M	23.5M
Total Current Liabilities	2.9M	4.5M	7.4M	6.1M	29.3M	30.8M
Total Stockholder Equity	59.8M	65.0M	138.7M	189.6M	118.3M	124.2M
Property Plant And Equipment Net	155.6K	466.0K	862.8K	683.0K	1.7M	1.8M
Current Deferred Revenue	390.6K	738.3K	1.3M	1.6M	1.9M	2.0M
Net Debt	(30.0M)	(29.2M)	(99.2M)	(152.6M)	(91.6M)	(87.0M)
Retained Earnings	(47.3M)	(65.7M)	(103.5M)	(141.4M)	(289.8M)	(275.3M)
Accounts Payable	1.0M	759.7K	4.5M	2.3M	6.0M	6.3M
Cash	30.1M	29.5M	99.9M	153.2M	93.1M	97.8M
Non Current Assets Total	30.7M	35.5M	33.8M	31.4M	38.4M	40.3M
Cash And Short Term Investments	30.1M	29.5M	99.9M	153.2M	94.5M	99.3M
Net Receivables	4.2M	6.7M	12.8M	12.1M	12.6M	13.2M
Common Stock Shares Outstanding	4.1B	4.7B	5.6B	6.3B	7.1B	7.4B
Liabilities And Stockholders Equity	65.2M	71.8M	147.6M	197.1M	151.4M	159.0M
Non Current Liabilities Total	2.5M	2.3M	1.5M	1.4M	3.8M	4.0M
Other Stockholder Equity	(45.5M)	(1.0)	(127.3M)	(173.0M)	(155.7M)	(147.9M)
Total Liab	5.4M	6.8M	8.9M	7.4M	33.1M	34.8M
Property Plant And Equipment Gross	155.6K	718.9K	1.3M	1.0M	2.6M	2.8M
Total Current Assets	34.5M	36.3M	113.8M	165.7M	113.0M	118.7M
Accumulated Other Comprehensive Income	14.3M	17.6M	11.4M	16.7M	37.8M	39.7M
Short Term Debt	60.9K	106.0K	184.2K	191.1K	912.5K	958.1K
Intangible Assets	30.5M	34.9M	32.7M	30.5M	34.1M	35.8M
Common Stock	92.8M	113.1M	230.8M	314.4M	370.3M	388.8M
Other Liab	2.5M	2.2M	987.1K	990.6K	1.1M	1.1M
Net Tangible Assets	29.3M	30.1M	106.0M	159.1M	183.0M	192.2M
Long Term Investments	80.6K	115.2K	252.4K	217.6K	2.4M	2.5M
Property Plant Equipment	155.6K	466.0K	862.8K	683.0K	614.7K	645.4K
Other Current Assets	194.1K	170.1K	1.1M	401.6K	5.9M	6.2M
Long Term Debt Total	8.4K	165.0K	489.3K	362.4K	326.2K	462.4K
Net Invested Capital	59.8M	65.0M	138.7M	188.4M	118.3M	85.8M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Imugene Stock Analysis

When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC